Clinical Trials Browser

Kidney Neoplasms × belzutifan × 90 days × Clear all

NCT05468697 2026-01-23

MK-6482-024

Phase 1/2 Active not recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

NCT06234605 2026-01-15

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

Phase 1 Recruiting

Carcinoma, Renal Cell, Kidney Neoplasms, Neoplasm Metastasis